Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Articles > Article · 2017
Authors: S. L. Hauser, A. Bar-Or, Ayşe Nur YÜCEYAR, G. Giovannoni, H. -P. Hartung, B. Hemmer, F. Lublin, X. Montalban, K. W. Rammohan, K. Selmaj, A. Traboulsee, J. S. Wolinsky, D. L. Arnold, G. Klingelschmitt, D. Masterman, P. Fontoura, S. Belachew, P. Chin, N. Mairon, H. Garren, L. Kappos
The New England journal of medicine, Journal Indexed in SCI Expanded, International, 2017, vol 376, pp 221-234
Summary
BACKGROUND